BioStem Technologies officer reports option and RSU holdings
BioStem Technologies, Inc. reported initial equity holdings for officer Katherine Gorrell (CLCO).
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
BioStem Technologies, Inc. reported initial equity holdings for officer Katherine Gorrell (CLCO). She holds stock options covering 101,146 shares of common stock at an exercise price of $4.6000 per share, expiring on April 27, 2036. She also holds restricted stock units representing 82,456 underlying shares of common stock. Both the options and RSUs vest 33% on April 27, 2027, the one-year anniversary of the grant date, with the remaining two-thirds vesting in equal quarterly installments over the subsequent two years.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
GORRELL KATHERINE
Role
CLCO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) F1 | -- | -- | -- |
| holding | Restricted Stock Unit F3, F2 | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 101,146 contracts (Direct);
Restricted Stock Unit — 82,456 contracts (Direct)
Footnotes (3)
- F1. These options vest according to the following schedule: 33% will vest on April 27, 2027, the one-year anniversary of the grant date, with the remaining options vesting in equal quarterly installments over the subsequent two year period.
- F2. These restricted stock units vest according to the following schedule: 33% will vest on April 27, 2027, the one year anniversary of the grant date, with the remaining units vesting in equal quarterly installments over the subsequent two year period.
- F3. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
Key Figures
Stock options underlying shares: 101,146 shares
Option exercise price: $4.6000 per share
Option expiration date: April 27, 2036
+2 more
5 metrics
Stock options underlying shares
101,146 shares
Stock Option (Right to Buy) for common stock held directly
Option exercise price
$4.6000 per share
Exercise price for stock options expiring April 27, 2036
Option expiration date
April 27, 2036
Expiration of stock options over 101,146 underlying shares
RSU underlying shares
82,456 shares
Restricted stock units representing contingent rights to common shares
Initial vesting date
April 27, 2027
33% of both options and RSUs vest on the one-year anniversary of the grant date
Key Terms
Stock Option (Right to Buy), Restricted Stock Unit, exercise price, contingent right
4 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)" for common stock"
Restricted Stock Unit financial
"security_title: "Restricted Stock Unit" with underlying common stock"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
exercise price financial
"conversion_or_exercise_price: "4.6000" as the exercise price of options"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
contingent right financial
"Each restricted stock unit represents a contingent right to receive one share"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does BioStem Technologies (BSEM) report in Katherine Gorrell’s Form 3?
The Form 3 reports initial equity holdings for officer Katherine Gorrell, including stock options and restricted stock units linked to BioStem Technologies’ common stock, with detailed vesting schedules starting in 2027.
How many stock options does Katherine Gorrell hold at BioStem Technologies (BSEM)?
Katherine Gorrell holds options over 101,146 shares of BioStem Technologies common stock at an exercise price of $4.6000 per share, expiring on April 27, 2036, as disclosed in her Form 3.
How many restricted stock units does Katherine Gorrell have at BioStem Technologies (BSEM)?
She holds 82,456 restricted stock units, each representing a contingent right to receive one share of BioStem Technologies common stock, subject to the vesting schedule described in the Form 3 footnotes.
What is the vesting schedule for Katherine Gorrell’s stock options at BioStem Technologies (BSEM)?
The options vest 33% on April 27, 2027, the one-year anniversary of the grant date, with the remaining options vesting in equal quarterly installments over the following two-year period.
What is the vesting schedule for Katherine Gorrell’s RSUs at BioStem Technologies (BSEM)?
The restricted stock units vest 33% on April 27, 2027, and the remaining two-thirds vest in equal quarterly installments over the next two years, mirroring the schedule of the stock options.
Does the Form 3 for BioStem Technologies (BSEM) show any buy or sell transactions?
No, the Form 3 reflects holdings of stock options and restricted stock units for Katherine Gorrell and does not report any purchase or sale transactions of BioStem Technologies common stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates